From ambition to delivery: what the National Cancer Plan means for care beyond the hospital
The publication of England’s National Cancer Plan marks an important moment for patients, clinicians and the wider health system. Much of the early commentary focused on the headline ambition that three in four people diagnosed with cancer will survive long term by 2035. But the full plan goes further than survival targets alone. It sets out a comprehensive vision for earlier diagnosis, more personalised treatment, reduced inequalities and better support for people living with and beyond cancer.
As an oncology clinician who has worked within the NHS, I recognise both the scale of this ambition and the reality facing cancer services today. Delivering this plan will require more than policy intent. It will depend on how care is delivered, where it happens and how different parts of the system work together.
Moving care closer to patients
One of the strongest themes in the published plan is the need to reduce variation in access, outcomes and experience across regions and communities. The plan places renewed emphasis on bringing services closer to where people live, whether through community diagnostics, improved screening uptake or better integration of care outside hospital settings.
From clinical experience, we know repeated hospital visits can be physically and emotionally draining for patients undergoing systemic anti-cancer treatment. For some, travel alone becomes a barrier to continuing care as planned. Specialist clinical cancer care delivered safely in the home can help address this challenge. It allows patients to receive treatment in a familiar environment, while reducing unnecessary pressure on acute services.
Personalised treatment needs personalised delivery
The plan also expands significantly on genomics, precision medicine and access to clinical trials, particularly for people with rare or complex cancers. As treatments become more targeted and tailored, the way we deliver them must evolve too.
Personalised medicine is not just about choosing the right therapy; it is about ensuring the right support surrounds that therapy which includes monitoring, symptom management and continuity of care. Specialist clinical teams working across hospital and community settings can help bridge this gap, ensuring patients remain closely supported even when care extends beyond the hospital.
Living well with and beyond cancer
Importantly, the plan acknowledges cancer care does not end when treatment does. There is a stronger focus on quality of life, recovery, and supporting people to remain in work and in their communities during and after treatment. This reflects what patients consistently tell us matters most: not only living longer, but living better. Care models that support people in their own homes can play a role here too by helping patients manage side effects, maintain independence and stay connected to everyday life while receiving complex treatment.
Partnership will determine success
Perhaps the clearest message from the published plan is that no single organisation can deliver this transformation alone. The scale of change required demands strong partnerships across the NHS, third-party providers, community services and innovators. Done well, these partnerships are not about shifting care away from the NHS, but about extending its reach with specialist, clinically governed solutions to support capacity, improve experience and reduce inequality.
The National Cancer Plan sets a compelling direction of travel. Turning that ambition into reality will depend on whether we are willing to rethink traditional boundaries of care and work together to deliver high-quality cancer services wherever patients need them most.